Non-Glycanated Biglycan and LTBP4: Leveraging the extracellular matrix for Duchenne Muscular Dystrophy therapeutics.
about
Non-Glycanated Biglycan and LTBP4: Leveraging the extracellular matrix for Duchenne Muscular Dystrophy therapeutics.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Non-Glycanated Biglycan and LT ...... scular Dystrophy therapeutics.
@en
Non-Glycanated Biglycan and LT ...... scular Dystrophy therapeutics.
@nl
type
label
Non-Glycanated Biglycan and LT ...... scular Dystrophy therapeutics.
@en
Non-Glycanated Biglycan and LT ...... scular Dystrophy therapeutics.
@nl
prefLabel
Non-Glycanated Biglycan and LT ...... scular Dystrophy therapeutics.
@en
Non-Glycanated Biglycan and LT ...... scular Dystrophy therapeutics.
@nl
P2860
P1433
P1476
Non-Glycanated Biglycan and LT ...... scular Dystrophy therapeutics.
@en
P2093
Elizabeth M McNally
Justin R Fallon
P2860
P356
10.1016/J.MATBIO.2018.02.016
P577
2018-02-23T00:00:00Z